BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
Project Continued Growth from Sales of AmnioWrap2®- -Financial Results Conference Call and Webcast on Monday, April 1, 2024 at 4:30 pm EDT- POMPANO BEACH,…
Stay updated with breaking news from Astem Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Project Continued Growth from Sales of AmnioWrap2®- -Financial Results Conference Call and Webcast on Monday, April 1, 2024 at 4:30 pm EDT- POMPANO BEACH,…
Ukrainian Defence Minister Rustem Umierov has published his property and income declaration for 2023, according to which his income in 2023 was over 5.5 million hryvnias (about US$145,000), and his wife's income was over 1.
30.01.2024 - BioStem provides a business update and highlights recent accomplishments Preliminary fourth quarter net revenues of $11.5 million and full year 2023 net revenues of $16.7 million National Pricing for Amniowrap2 effective January 1st in all 50 ... Seite 1
POMPANO BEACH, Fla., Dec. 19, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for
Pricing Provides AmnioWrap2™ Reimbursement in All MAC Regions We Manufacture Products That Change Lives We Manufacture Products That Change Lives POMPANO BEACH, Fla., Dec. 14, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced that the Center for Medicare Services (CMS) has established national pricing for its produc